Ignite Creation Date:
2025-12-24 @ 4:50 PM
Ignite Modification Date:
2026-01-04 @ 4:11 PM
Study NCT ID:
NCT00503750
Status:
COMPLETED
Last Update Posted:
2012-06-25
First Post:
2007-07-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Neoadjuvant Trial of Trastuzumab in Combination With Dose-Dense ABI-007 (Abraxane™)
Sponsor:
Emory University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-04
Start Date Type:
None
Primary Completion Date:
2011-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-07
Completion Date Type:
ACTUAL
First Submit Date:
2007-07-17
First Submit QC Date:
None
Study First Post Date:
2007-07-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-03-26
Results First Submit QC Date:
None
Results First Post Date:
2012-06-14
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-06-16
Last Update Post Date:
2012-06-25
Last Update Post Date Type:
ESTIMATED